ImageIQ Inc., Becomes Cleveland Clinic Innovations Spin-off CRO Company for Research, Medical Device and Pharmaceutical Image Acquisition, Visualization and Analysis; CompanyAppoints Timothy Kulbago as President/CEOMay 26, 2011 | Industry News Release
ImageIQ, an imaging contract research organization (CRO) specializing in advanced medical image acquisition, analysis and visualization, today announced the company’s spin-out of technology and expertise developed at Cleveland Clinic Innovations. Concurrent with the formation of the company, Cleveland Clinic Innovations announces the appointment of Timothy Kulbago as President and CEO of ImageIQ.
ImageIQ combines software, engineering and imaging expertise for research, medical device and pharmaceutical organizations. Incubated within Cleveland Clinic over an eight-year period, ImageIQ provides customized image analytics and data analysis, delivering objective quantitative evidence that speeds time to discovery and market entry, reduces internal overhead, improves grant attractiveness and fundability, and supports regulatory compliance. By advancing the speed of research, ImageIQ customers can extend their expertise and abilities and complete work quickly, allowing innovative staff members to focus on creative solutions to research.
“I am excited to be part of the ImageIQ team,” stated Mr. Kulbago. “We have an opportunity to bring Cleveland Clinic expertise in custom image analysis to the broader market. We have already demonstrated our unique capabilities to several prominent research labs and medical device manufacturers.” Kulbago has over 14 years of experience in the medical imaging industry including General Manager, Chief Technology Officer and Chief Strategy Officer with Merge Healthcare. Before joining the medical industry, Kulbago spent several years as a Research Assistant at the Applied Research Laboratory at The Pennsylvania State University, developing virtual reality training and visualization systems.
“We are pleased to add ImageIQ to our expanding portfolio of companies,” said Chris Coburn, Executive Director of Cleveland Clinic Innovations. “Cleveland is an emerging hub for healthcare IT start-ups, and ImageIQ has a compelling blend of software engineering and biomedical expertise. With 15 years of experience as a healthcare innovator and company leader, Tim Kulbago brings the full set of tools to drive ImageIQ to be a market leader.”
ImageIQ engineers pair their technical image analysis expertise with their vast experience in deriving solutions for biologically rooted problems to generate unique solutions that are efficient, precise, and accurate. Consequently, research based studies or clinical trials that previously limited dataset sizes to accommodate for time required for pathologist/radiologist reads, are now able to increase study sizes, throughput and statistical power with the aid of tailored Image IQ analysis software. Furthermore, ImageIQ offers the option of exporting quantified data in visual form (i.e. superimposed, pseudo-colored 2D/3D/4D images) for the validation of accuracy by a trained reader (technician/pathologist/radiologist).
ImageIQ is an imaging Contract Research Organization (CRO) that combines software engineering with biomedical and imaging expertise to provide quantitative visual analysis that enhances R&D and product efficacy/safety testing for research, medical device and pharmaceutical organizations. Incubated within Cleveland Clinic for the better part of a decade, ImageIQ provides customized image analytics and reporting, delivering objective quantitative evidence that speeds time to discovery and market entry, reduces internal overhead and improves grant proposal attractiveness and fundability. By advancing the speed of research, ImageIQ customers can extend their expertise and abilities and complete work quickly, allowing innovative staff members to focus on creative solutions to research.
About Cleveland Clinic Innovations
Cleveland Clinic Innovations, the corporate venturing arm of Cleveland Clinic, promotes innovation and is responsible for the commercialization of all Cleveland Clinic technologies. Innovations advances product-oriented innovation and transforms promising therapies, devices, diagnostics and software into beneficial medical products, via spin-off companies, licensees and equity partnerships. There have been 36 companies spun off from the Clinic in the last decade, more than 200 licenses, more than $450 million in equity investment in those spin-offs and a record number of inventions in virtually every area of activity at Cleveland Clinic. In 2010, Cleveland Clinic Innovations was named one of the Most Influential Healthcare Corporate Venturing Divisions by the Global Corporate Venturing.